)
Canopy Growth (WEED) investor relations material
Canopy Growth Q4 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Fiscal 2026 was transformative, with streamlined operations, cost base reset, and resource reallocation to high-return areas.
Net revenue grew 6% to CAD 285 million, with Q4 consolidated net revenue up 10% year-over-year to CAD 71.2 million.
Canada adult-use cannabis net revenue rose 20% for the year, while Canada medical cannabis grew 18% for the year and 27% in Q4.
Acquisition of MTL Cannabis established leadership in Canadian medical cannabis and accelerated integration and synergy realization.
Recapitalization strengthened the balance sheet, stabilized cash, and extended debt maturities to 2031, ending FY2026 with CAD 131 million net cash.
Financial highlights
Q4 cannabis net revenue reached CAD 54.5 million, up 20% year-over-year; full-year cannabis net revenue was CAD 213.9 million, up 15%.
International cannabis net revenue in Q4 was CAD 8.6 million, up 68% year-over-year, mainly from Poland and Germany.
Adjusted gross margin for cannabis in Q4 was 26%, up from 12% in Q4 2025; consolidated Q4 adjusted gross margin was 27%.
Adjusted EBITDA loss for Q4 was CAD 6 million, a CAD 3 million improvement year-over-year; full-year adjusted EBITDA loss was CAD 20.2 million, improved by 14%.
Free cash outflow improved to CAD 69.1 million in FY2026 from CAD 176.6 million in FY2025.
Outlook and guidance
Expectation to achieve positive Adjusted EBITDA during fiscal 2027, with improvements more pronounced in the second half as MTL Cannabis integration progresses.
Anticipate slower growth in the first half of fiscal 2027 due to integration and product portfolio adjustments.
Strengthened cultivation practices and ongoing cost discipline projected to enhance gross margin and reduce operating expenses.
Early fiscal 2027 trends show continued market share momentum and top-three positions in key Canadian categories.
International and recreational segments expected to drive overall growth, with Canadian medical facing headwinds but aiming for flat EBITDA.
- Acquisition creates Canada's top medical cannabis provider and accelerates profitability.WEED
M&A presentation16 Apr 2026 - Net loss narrowed 49% year-over-year as Canadian cannabis revenue grew and cost savings took hold.WEED
Q3 202613 Apr 2026 - Q3 FY2026 saw stable revenue, improved margins, and strategic moves to lead in cannabis markets.WEED
Investor presentation23 Mar 2026 - Registering 18.7M shares for resale, with proceeds from warrants supporting investments amid financial risk.WEED
Registration Filing6 Feb 2026 - Gross margin up 35%, EBITDA loss narrowed 77%, medical and international growth strong.WEED
Q1 20251 Feb 2026 - All proposals passed, with U.S. regulatory changes highlighted as a key opportunity.WEED
AGM 202420 Jan 2026 - Gross margin rose to 35% as Storz & Bickel and medical cannabis drove improved profitability.WEED
Q2 202515 Jan 2026 - 52.3 million shares registered for resale amid financial uncertainty and high risk.WEED
Registration Filing9 Jan 2026 - Medical cannabis and Storz & Bickel growth drove improved margins and reduced losses.WEED
Q3 202523 Dec 2025
Next Canopy Growth earnings date
Next Canopy Growth earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)